DifGen Wins FDA IND Clearance for Breast Cancer Therapy
Miramar, Fla., July 27, 2026 DifGen Pharmaceuticals LLC has announced that the U.S. Food and Drug Administration (FDA) has...
advanced solid tumors
Advertisement
Insilico Medicine Presents ISM6331 Phase 1 Data at ESMO
Cambridge, MA, July 27, 2026 Insilico Medicine has announced that first-in-human Phase 1 clinical trial data for ISM6331, its...
MacroGenics Reports Positive Phase 1 MGC026 Cancer Study Update
ROCKVILLE, MD, July 23, 2026 MacroGenics, Inc. announced a significant clinical update from its ongoing Phase 1 study of...
Oncotelic Publishes Deciparticle Data Supporting Sapu003 Clinical Trial
Agoura Hills, Calif., July 22, 2026 Oncotelic Therapeutics and Sapu Nano announced the publication of a peer-reviewed study in...
Immunome Doses First Patient in Phase 1 Trial of IM-1617
BOTHELL, Wash., June 11, 2026 Immunome, Inc. announced the first patient has been dosed in a Phase 1 first-in-human...
Advertisements
Harbour BioMed Clears Regulatory Milestone for HBM7004
CAMBRIDGE, Massachusetts; ROTTERDAM, Netherlands; SHANGHAI, China, June 10, 2026 Harbour BioMed announced that the National Medical Products Administration (NMPA)...
Harbour BioMed Receives FDA IND Clearance for HBM7004 Solid Tumor Trial
CAMBRIDGE, Massachusetts, ROTTERDAM, Netherlands, and SHANGHAI, China, May 8, 2026 Harbour BioMed announced that the U.S. Food and Drug...
Advertisement
